| 2.15 Data as of May 24 |  +0.02 / +0.94%Today’s Change | 1.44 Today|||52-Week Range 3.53 | -19.48% Year-to-Date |
| Previous close | 2.13 |
| Today’s open | 2.12 |
| Day’s range | 2.10 - 2.18 |
| Volume | 427,348 |
| Average volume (3 months) | 325,331 |
| Market cap | $170.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -2,850.00% |
| Earnings growth (this year) | +101.21% |
| Earnings growth (next 5 years) | +13.70% |
| Revenue growth (last year) | +24.62% |
| P/E ratio | NM |
| Price/Sales | 1.19 |
| Price/Book | 1.34 |
| Today’s change | Today’s % change | |
|---|---|---|
| CYTXCytori Therapeutics ... | -0.07 | -2.72% |
| UTMDUtah Medical Product... | -0.06 | -0.12% |
| ROCMRochester Medical Co... | 0.00 | 0.00% |
| RMTIRockwell Medical Inc | -0.18 | -4.55% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $144.5M |
| Annual profit (last year) | -$38.0M |
| Net profit margin | -26.29% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President, CEO & VP-Global Sales Stephen J. Fanning |
Vice President- Operations Douglas W. Heigel |
Corporate headquarters Hayward, California |
.
